Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Clinical trial NCT05704894 · UNKNOWN

Trial details

NCT number: NCT05704894
Sponsor: Blau Farmaceutica S.A.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia Neoplasms Chemotherapeutic-Induced Anemia

Start date: 2023-05-01
Primary completion: 2025-05-01
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.